Sun Life Financial (LIE) Q2 2026 Earnings Report

Positive — The call presented broad, double‑digit underlying EPS growth, record results in Canada, strong Asia sales and advisor expansion, accelerating asset management momentum (large fundraising and mandate wins), solid capital metrics (LICAT 145%, organic capital generation 41%), and continued investment in digital/AI. Material headwinds include MFS outflows and industry fee pressure, dental/Medicaid contraction in the U.S., and some margin/mix pressure in Asia (Hong Kong) and seasonal reserve timing in stop‑loss. On balance the company’s diversified earnings growth, capital strength, and clear operational progress outweigh the identified challenges.

Management reinforced its medium‑term targets and capital flexibility: underlying EPS growth target 10% (Q2 delivered 13%, underlying EPS CAD 2.02, underlying net income CAD 1.12B), underlying ROE target ~20% (Q2: 19.1%), dividend‑payout target 40–50% (Q2: 48%, CAD 0.5B returned, 3.8% yield), and a strong capital position (LICAT 145%, holding‑company cash CAD 2.3B, financial leverage 23.8%, book value/share CAD 42.49, organic capital generation 41% vs guidance 30–40%). They call out balance‑sheet and sales metrics (total CSM CAD 15.3B, +12% YoY; Asia CSM >CAD 7B, +90% since IFRS 17; insurance sales +20%; Asia sales CAD 875M, +20%; Hong Kong advisors +28% to ~4,000; Indonesia sales +69%; Canada AUMA CAD 286B, +18%) and asset‑management momentum (Sun Life AM underlying net income $262M, capital raising $4.7B, deployments $6.2B, Crescent $10.8B investable capital, $3.2B continuation vehicle, Aditya Birla AUM doubled to $113B, MFS active ETF AUM $3B), while setting SLC operating‑margin expectations >30% (mid‑30s over five years) and an SLC medium‑term earnings growth ambition of ~20%; they also renewed a NCIB to repurchase up to 10M shares (0.8M repurchased to date).